DEPOMED INC (DEPO) is a publicly traded company in the Unknown sector. Across all available filings, 22 corporate insiders have executed 319 transactions totaling $14.3M, demonstrating a bearish sentiment with -$11.7M in net insider flow. The most recent transaction on May 11, 2018 involved a sale of 19,674 shares valued at $139.1K.
No significant insider buying has been recorded for DEPO in the recent period.
No significant insider selling has been recorded for DEPO in the recent period.
Based on recent SEC filings, insider sentiment for DEPO is bearish with an Insider Alignment Score of 9/100 and a net flow of -$11.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at DEPOMED INC (DEPO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 22 insiders are actively trading DEPO stock, having executed 319 transactions in the past 90 days. The most active insider is Thadd M. Vargas (Executive), who has made 37 transactions totaling $8.0M.
Get notified when executives and directors at DEPO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| May 11, 2018 | M. Gosling Matthew | Executive | Sale | 19,674 | $7.07 | $139.1K | |
| Mar 31, 2018 | J. Moretti August | Executive | Payment | 6,975 | $6.59 | $46.0K | |
| Mar 31, 2018 | M. Gosling Matthew | Executive | Payment | 10,326 | $6.59 | $68.0K | |
| Mar 7, 2018 | M. Gosling Matthew | Executive | Sale | 45,519 | $6.58 | $299.5K | |
| Dec 14, 2017 | J. Higgins Arthur | Executive | Purchase | 75,000 | $8.16 | $612.0K | Large |
| Dec 1, 2017 | M. Gosling Matthew | Executive | Payment | 13,813 | $7.11 | $98.2K | |
| Dec 1, 2017 | J. Moretti August | Executive | Payment | 10,336 | $7.11 | $73.5K | |
| Dec 1, 2017 | D. Staple Peter | Executive | Option Exercise | 15,000 | $1.49 | $22.4K | |
| Dec 1, 2017 | J. Higgins Arthur | Executive | Payment | 13,101 | $7.11 | $93.1K | |
| Jun 13, 2017 | M. Vargas Thadd | Executive | Option Exercise | 43,000 | $6.11 | $262.7K | |
| Jun 13, 2017 | M. Vargas Thadd | Executive | Option Exercise | 45,000 | $6.08 | $273.6K | |
| Jun 13, 2017 | M. Vargas Thadd | Executive | Option Exercise | 19,320 | $7.12 | $137.6K | |
| Jun 13, 2017 | M. Vargas Thadd | Executive | Sale | 19,816 | $9.60 | $190.2K | |
| Jun 13, 2017 | M. Vargas Thadd | Executive | Sale | 21,751 | $9.59 | $208.6K | |
| Jun 13, 2017 | M. Vargas Thadd | Executive | Sale | 160,820 | $9.53 | $1.5M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 56 | $13.0M | 50.7% |
Exercise(M) | 88 | $6.5M | 25.5% |
Payment(F) | 37 | $4.5M | 17.4% |
Purchase(P) | 113 | $1.3M | 5.2% |
Exercise (Options)(X) | 1 | $324.0K | 1.3% |
Gift(G) | 22 | $0 | 0.0% |
Award(A) | 2 | $0 | 0.0% |
Insider selling pressure at DEPOMED INC has increased, with 22 insiders executing 319 transactions across all time. Total sales of $13.0M significantly outpace purchases of $1.3M, resulting in a net outflow of $11.7M. This selling activity appears largely discretionary, which may warrant closer attention from investors.